As for the impact of cyclin D1 on diagnosis, the cut‐off found was the same (statistically significant), with better sensitivity and specificity in the diagnosis of high‐grade DIA compared with low‐grade DIA and in the diagnosis of GBM compared with other DIAs. Here, CCND1 is linked to glioblastoma.